ABL Bio ranked among the top searched stocks for 2 days in the past month.


As of 12:30 PM on the 16th, ABL Bio is trading at 35,350 KRW, down 2.08% from the previous day. This represents a 19.43% increase compared to August 21. ABL Bio is known as a specialized company developing bio-pharmaceuticals based on antibody therapeutics.

Today, foreigners have sold a net 9,000 shares of ABL Bio, while institutions have bought a net 5,000 shares, according to provisional data. Over the past 5 days, individual investors have bought a net 631,051 shares, while foreigners and institutions have sold a net 353,211 shares and 241,977 shares, respectively.


On September 15, ABL Bio was a market topic with the news of 'rise due to development of COVID-19 antibody therapeutics.'





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing